Student or educator? Sign up with your school email and get 6 months of Pro free.

The DOI matches its Crossref record; 66 of the 66 references it cites were found in a registry or an index; 46 of the 60 sources its claims cite were checked for support.

Overlooked Candida glabrata petites are echinocandin tolerant, induce host inflammatory responses, and display poor in vivo fitness

Open access

Abstract

Small colony variants are relatively common among some bacterial species and are associated with poor prognosis and recalcitrant infections. Similarly, Candida glabrata— a major intracellular fungal pathogen—produces small and slow-growing respiratory-deficient colonies, termed “petite.” Despite reports of clinical petite C. glabrata strains, our understanding of petite behavior in the host remains obscure. Moreover, controversies exist regarding in-host petite fitness and its clinical relevance. Herein, we employed whole-genome sequencing (WGS), dual-RNAseq, and extensive ex vivo and in vivo studies to fill this knowledge gap. WGS identified multiple petite-specific mutations in nuclear and mitochondrially encoded genes. Consistent with dual-RNAseq data, petite C. glabrata cells did not replicate inside host macrophages and were outcompeted by their non-petite parents in macrophages and in gut colonization and systemic infection mouse models. The intracellular petites showed hallmarks of drug tolerance and were relatively insensitive to the fungicidal activity of echinocandin drugs. Petite-infected macrophages exhibited a pro-inflammatory and type I IFN-skewed transcriptional program. Interrogation of international C. glabrata blood isolates ( n = 1000) showed that petite prevalence varies by country, albeit at an overall low prevalence (0%–3.5%). Collectively, our study sheds new light on the genetic basis, drug susceptibility, clinical prevalence, and host-pathogen responses of a clinically overlooked phenotype in a major fungal pathogen. Importance Candida glabrata is a major fungal pathogen, which is able to lose mitochondria and form small and slow-growing colonies, called “petite.” This attenuated growth rate has created controversies and questioned the clinical importance of petiteness. Herein, we have employed multiple omics technologies and in vivo mouse models to critically assess the clinical importance of petite phenotype. Our WGS identifies multiple genes potentially underpinning petite phenotype. Interestingly, petite C. glabrata cells engulfed by macrophages are dormant and, therefore, are not killed by the frontline antifungal drugs. Interestingly, macrophages infected with petite cells mount distinct transcriptomic responses. Consistent with our ex vivo observations, mitochondrial-proficient parental strains outcompete petites during systemic and gut colonization. Retrospective examination of C. glabrata isolates identified petite prevalence a rare entity, which can significantly vary from country to country. Collectively, our study overcomes the existing controversies and provides novel insights regarding the clinical relevance of petite C. glabrata isolates.

Overview

CoChat Summary

## TL;DR

This study shows that *Candida glabrata* petites are generally poor at intracellular growth and in vivo colonization, but they tolerate echinocandins better than non-petite cells and trigger a pro-inflammatory macrophage response. Across >1,000 blood isolates, petites were rare overall (0.9%) but varied by country (0%–3.3%).

## Key findings

  • In THP-1 macrophages, petite isolates did not show intracellular growth, while non-petite isolates replicated at 24 and 48 hpi; petites were also more readily phagocytosed than non-petites.
  • Dual RNA-seq showed that petite-infected macrophages induced pro-inflammatory pathways, including “Interferon alpha response,” “Interferon gamma response,” “TNFA signaling via NFKB,” and “Inflammatory response,” and were enriched for the human M1 transcriptional module.
  • Petite isolates showed slower killing than non-petites under echinocandin exposure: they were significantly less susceptible to micafungin (0.125 µg/mL) and caspofungin (0.25 µg/mL), including inside macrophages; by contrast, they were killed similarly to non-petites by amphotericin B (2 µg/mL).
  • In mouse models, petites were outcompeted by non-petite counterparts in gut colonization and systemic infection, but under caspofungin treatment their survival in vivo was higher than in untreated controls.

## Methods

  • The study combined clinical and laboratory-derived *C. glabrata* petites with comparative genomics (WGS), macrophage infection assays in human THP-1 cells, dual RNA-seq, antifungal killing assays, and mouse gut colonization/systemic infection competition models.
  • Clinical sampling included 37 isolates in the lab collection, plus a retrospective screen of >1,000 bloodstream isolates from Austria (n=600), Turkey (n=260), and Pakistan (n=220).
  • Main analyses included variant calling from Illumina WGS, differential expression analysis with DESeq2, and gene set enrichment analysis (GSEA) / GO enrichment for host and fungal transcriptomes.

## Limitations

  • The authors state that the underlying genetic drivers of the petite phenotype are “complex” and that the contribution of multiple genes is “yet to be fully determined.”
  • They note that the lack of a closely related parental strain for DPL248 limited identification of recently acquired mutations.
  • Evident from the text: the in vivo competition experiments were acute mouse infection/colonization models, which the authors themselves suggest may miss host niches or longer-term dynamics relevant to human persistence.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1128/mbio.01180-23

Cites

66 of 66 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Fig 1 Characteristics of petite C. glabrata isolates. All petite isolates included in this study were fluconazole resistant (A) and did not carry PDR1 gain-of-function mutations, as confirmed by PDR1 sequencing. Petite isolates have a higher basal level of PDR1 and efflux pumps under its control (CDR1, CDR2, and SNQ2) once measured by real-time PCR (three biological replicates, ***<0.01, ****<0.001, two-tailed t-test) (B). Petites had a lower ATP level (five biological replicates, ****<0.001, two-tailed t-test) (C) and mitochondrial membrane potential (three biological replicates, ***<0.01 and **=0.01, two-tailed t-test) (D) than their respiratory proficient counterparts. ATP, adenosine triphosphate.
Fig 1 Characteristics of petite C. glabrata isolates. All petite isolates included in this study were fluconazole resistant (A) and did not carry PDR1 gain-of-function mutations, as confirmed by PDR1 sequencing. Petite isolates have a higher basal level of PDR1 and efflux pumps under its control (CDR1, CDR2, and SNQ2) once measured by real-time PCR (three biological replicates, ***<0.01, ****<0.001, two-tailed t-test) (B). Petites had a lower ATP level (five biological replicates, ****<0.001, two-tailed t-test) (C) and mitochondrial membrane potential (three biological replicates, ***<0.01 and **=0.01, two-tailed t-test) (D) than their respiratory proficient counterparts. ATP, adenosine triphosphate.CC BY · PubMed Central
Fig 2 MIP1 sequencing of diverse clinical isolates revealed that polymorphisms occurring in isolates better reflect the sequence type rather than petite phenotype (A). The interaction of petite and their respective parental isolates with THP1 macrophages. Macrophages infected with respective isolates and intracellular replication were measured 3, 6, 24, and 48 h after infection, and the data were normalized against the initial inoculum used to treat the macrophages. Petite isolates did not show intracellular replication, unlike their respiratory proficient isolates (four to eight biological replicates, ***<0.001, two-tailed t-test) (B), whereas petite isolates had a significantly higher rate of phagocytosis rate (four biological replicates, **<0.01, two-tailed t-test) (C). Macrophages were infected with fluorescein isothiocyanate (FITC)-stained BYP40 and NYP41 and counterstained with AF647 after macrophage lysis at each timepoints, and the single and double positive events were measured by fluorescent-activated cell sorting (FACS). FITC staining and AF647 counterstaining of intracellular BYP40 and BYP41 revealed that petites have an extremely limited growth as all cells were double-stained, while BYP40 showed a significant intracellular growth as evidenced by a high proportion of single-stained cells (three biological replicates) (D). Genomic interaction of green fluorescent protein (GFP) and red fluorescent protein (RFP) into CBS138 did not impact the intracellular growth and both transformants showed equally replicated inside the macrophages (four biological replicates) (E). RFP-expressing petite isolates were effectively phagocytosed by THP1 macrophages (four biological replicates, ****<0.00001, two-tailed t-test) (F), whereas they were outcompeted by their parental strains (nine biological replicates, ***<0.01 and ****<0.00001, two-tailed t-test) (G). Petite mutants enter a near dormant state after internalization by macrophages. The ATP level of BYP40 and BYP41 was normalized against colony-forming unit (CFU) incubated in RPMI or macrophages at different timepoints. Intracellular BYP41 had a significantly lower ATP level at early hours, whereas its ATP level was significantly higher than BYP40 48 h (six biological replicates) (H). Unlike their parental isolates, petite isolates imposed the least cytotoxicity 24 h post-infection as measured by lactate dehydrogenase (LDH) (eight biological replicates, ****<0.00001, two-tailed t-test) (I). FACS, fluorescent-activated cell sorting.
Fig 2 MIP1 sequencing of diverse clinical isolates revealed that polymorphisms occurring in isolates better reflect the sequence type rather than petite phenotype (A). The interaction of petite and their respective parental isolates with THP1 macrophages. Macrophages infected with respective isolates and intracellular replication were measured 3, 6, 24, and 48 h after infection, and the data were normalized against the initial inoculum used to treat the macrophages. Petite isolates did not show intracellular replication, unlike their respiratory proficient isolates (four to eight biological replicates, ***<0.001, two-tailed t-test) (B), whereas petite isolates had a significantly higher rate of phagocytosis rate (four biological replicates, **<0.01, two-tailed t-test) (C). Macrophages were infected with fluorescein isothiocyanate (FITC)-stained BYP40 and NYP41 and counterstained with AF647 after macrophage lysis at each timepoints, and the single and double positive events were measured by fluorescent-activated cell sorting (FACS). FITC staining and AF647 counterstaining of intracellular BYP40 and BYP41 revealed that petites have an extremely limited growth as all cells were double-stained, while BYP40 showed a significant intracellular growth as evidenced by a high proportion of single-stained cells (three biological replicates) (D). Genomic interaction of green fluorescent protein (GFP) and red fluorescent protein (RFP) into CBS138 did not impact the intracellular growth and both transformants showed equally replicated inside the macrophages (four biological replicates) (E). RFP-expressing petite isolates were effectively phagocytosed by THP1 macrophages (four biological replicates, ****<0.00001, two-tailed t-test) (F), whereas they were outcompeted by their parental strains (nine biological replicates, ***<0.01 and ****<0.00001, two-tailed t-test) (G). Petite mutants enter a near dormant state after internalization by macrophages. The ATP level of BYP40 and BYP41 was normalized against colony-forming unit (CFU) incubated in RPMI or macrophages at different timepoints. Intracellular BYP41 had a significantly lower ATP level at early hours, whereas its ATP level was significantly higher than BYP40 48 h (six biological replicates) (H). Unlike their parental isolates, petite isolates imposed the least cytotoxicity 24 h post-infection as measured by lactate dehydrogenase (LDH) (eight biological replicates, ****<0.00001, two-tailed t-test) (I). FACS, fluorescent-activated cell sorting.CC BY · PubMed Central
Fig 3 Principal component analysis (PCA) plot of all studied C. glabrata samples across studied conditions. The plot is based on vst-transformed read count data generated by DESeq2. Labels on the data points correspond to timepoints of the experiments. Percentages on PC1 and PC2 axes indicate the total amount of variance described by each axis (A). GO term enrichment analysis (category “Biological Process”) of up-regulated genes of C. glabrata at a given comparison shown on the X axis. The numbers underneath the comparisons correspond to the “counts” of clusterProfiler (i.e., total number of genes assigned to GO categories). GeneRatio corresponds to the ratio between the number of input genes assigned to a given GO category and “counts.” Only significant (P adj < 0.05) enrichments are shown. Adjustment of P-values is done by Benjamini-Hochberg procedure (B). Petitness-specific GO terms such as tRNA and rRNA related processes, biosynthesis of several amino acids as arginine and lysine, among others. When compared to laboratory-derived petites, clinical petites showed down-regulation of carbohydrate biosynthesis and fungal cell-wall-related processes. Finally, the comparisons of non-clinical strains of normal size showed down-regulation of various processes in the clinical stains, such as nucleosome and mitotic spindle assembly, methionine, and acetate metabolism (C). Principal component analysis plot of all studied macrophage samples. The plot is based on vst-transformed read count data generated by DESeq2. Labels on the data points correspond to internal sample identifiers. Percentages on PC1 and PC2 axes indicate the total amount of variance described by each axis (D). GO term enrichment analysis (category “Biological Process”) of up-regulated genes of macrophages infected with C. glabrata strains (as depicted on X axis) compared to unchallenged macrophages (E). The numbers underneath the comparisons correspond to the “counts” of clusterProfiler (i.e., total number of genes assigned to GO categories). GeneRatio corresponds to the ratio between the number of input genes assigned to a given GO category and “counts.” Only significant (P adj < 0.05) enrichments are shown. Adjustment of P-values is done by Benjamini-Hochberg procedure. C. glabrata petite strains induce a pro-inflammatory transcriptional program in human THP-1 macrophage cells. Summary data of differentially expressed transcripts in THP-1 macrophages at 24 h post-challenge; comparisons are between THP-1 transcriptomes challenged with petite vs non-petite C. glabrata laboratory or clinical strains (F). Gene set enrichment analysis (GSEA) indicating significantly enriched “Hallmark” pathways of the Molecular Signatures Database, based on the RNA-seq data from THP-1 cells at 24 h post-fungal challenge. The pathways are displayed based on the normalized enrichment score (NES) and the false discovery rate (FDR). The dotted line marks an FDR value of 0.25, while a select top enriched pathways are indicated Blue (enriched in non-petite) and Red (enriched in Petite) (G). GSEA enrichment plots depicting enrichment of the M1 macrophage transcriptional module (29) comparing transcriptomes THP-1 cells challenged with the petite vs non-petite C. glabrata laboratory or clinical strains at 24 h post-challenge (H). The P value reported here is the nominal P-value, while NES is the normalized enrichment score.
Fig 3 Principal component analysis (PCA) plot of all studied C. glabrata samples across studied conditions. The plot is based on vst-transformed read count data generated by DESeq2. Labels on the data points correspond to timepoints of the experiments. Percentages on PC1 and PC2 axes indicate the total amount of variance described by each axis (A). GO term enrichment analysis (category “Biological Process”) of up-regulated genes of C. glabrata at a given comparison shown on the X axis. The numbers underneath the comparisons correspond to the “counts” of clusterProfiler (i.e., total number of genes assigned to GO categories). GeneRatio corresponds to the ratio between the number of input genes assigned to a given GO category and “counts.” Only significant (P adj < 0.05) enrichments are shown. Adjustment of P-values is done by Benjamini-Hochberg procedure (B). Petitness-specific GO terms such as tRNA and rRNA related processes, biosynthesis of several amino acids as arginine and lysine, among others. When compared to laboratory-derived petites, clinical petites showed down-regulation of carbohydrate biosynthesis and fungal cell-wall-related processes. Finally, the comparisons of non-clinical strains of normal size showed down-regulation of various processes in the clinical stains, such as nucleosome and mitotic spindle assembly, methionine, and acetate metabolism (C). Principal component analysis plot of all studied macrophage samples. The plot is based on vst-transformed read count data generated by DESeq2. Labels on the data points correspond to internal sample identifiers. Percentages on PC1 and PC2 axes indicate the total amount of variance described by each axis (D). GO term enrichment analysis (category “Biological Process”) of up-regulated genes of macrophages infected with C. glabrata strains (as depicted on X axis) compared to unchallenged macrophages (E). The numbers underneath the comparisons correspond to the “counts” of clusterProfiler (i.e., total number of genes assigned to GO categories). GeneRatio corresponds to the ratio between the number of input genes assigned to a given GO category and “counts.” Only significant (P adj < 0.05) enrichments are shown. Adjustment of P-values is done by Benjamini-Hochberg procedure. C. glabrata petite strains induce a pro-inflammatory transcriptional program in human THP-1 macrophage cells. Summary data of differentially expressed transcripts in THP-1 macrophages at 24 h post-challenge; comparisons are between THP-1 transcriptomes challenged with petite vs non-petite C. glabrata laboratory or clinical strains (F). Gene set enrichment analysis (GSEA) indicating significantly enriched “Hallmark” pathways of the Molecular Signatures Database, based on the RNA-seq data from THP-1 cells at 24 h post-fungal challenge. The pathways are displayed based on the normalized enrichment score (NES) and the false discovery rate (FDR). The dotted line marks an FDR value of 0.25, while a select top enriched pathways are indicated Blue (enriched in non-petite) and Red (enriched in Petite) (G). GSEA enrichment plots depicting enrichment of the M1 macrophage transcriptional module (29) comparing transcriptomes THP-1 cells challenged with the petite vs non-petite C. glabrata laboratory or clinical strains at 24 h post-challenge (H). The P value reported here is the nominal P-value, while NES is the normalized enrichment score.CC BY · PubMed Central
Fig 4 Petite phenotype is advantageous under certain stresses and echinocandin treatment. Petite and parental strains were resuspended in RPMI containing tunicamycin (endoplasmic reticulum stress; 10 µg/mL), SDS (membrane stress; 0.02%), Congo Red (cell wall integrity; 10 µg/mL), and menadione (0.5 mM); survival was assessed at designated timepoints; and the survival data were normalized to untreated control. Petites had a higher tolerance to endoplasmic reticulum (four biological replicates, ***<0.01 and ****<0.00001, two-tailed t-test) and membrane stresses (four biological replicates, **=0.01, two-tailed t-test), whereas petite isolates showed similar tolerance to oxidative and cell wall stresses (all experiments were carried out in four biological replicates, **=0.01, ***<0.01 and ****<0.00001, two-tailed t-test) (A). The survival assessment of planktonic BYP40 and BYP41 under micafungin (0.125 µg/mL) and caspofungin (0.25 µg/mL) revealed that BYP41 was more tolerant and showed monophasic and slow-killing dynamic reminiscent of tolerance phenotype defined in bacteriology (eight biological replicates) (B). Intracellular BYP41 was not responsive to either micafungin or caspofungin, whereas intracellular parental strains showed 1,000- to 10,000-fold killing compared to petite strains (four biological replicates) (C). Intracellular BYP40 and CBS138 were outcompeted by BYP41 and D5, respectively, under micafungin treatment (three biological replicates, ****<0.00001, two-tailed t-test) (D and E). BYP40 and BYP41 were equally killed by AMB in either planktonic (eight biological replicates) or intracellular conditions (four biological replicates) (F).
Fig 4 Petite phenotype is advantageous under certain stresses and echinocandin treatment. Petite and parental strains were resuspended in RPMI containing tunicamycin (endoplasmic reticulum stress; 10 µg/mL), SDS (membrane stress; 0.02%), Congo Red (cell wall integrity; 10 µg/mL), and menadione (0.5 mM); survival was assessed at designated timepoints; and the survival data were normalized to untreated control. Petites had a higher tolerance to endoplasmic reticulum (four biological replicates, ***<0.01 and ****<0.00001, two-tailed t-test) and membrane stresses (four biological replicates, **=0.01, two-tailed t-test), whereas petite isolates showed similar tolerance to oxidative and cell wall stresses (all experiments were carried out in four biological replicates, **=0.01, ***<0.01 and ****<0.00001, two-tailed t-test) (A). The survival assessment of planktonic BYP40 and BYP41 under micafungin (0.125 µg/mL) and caspofungin (0.25 µg/mL) revealed that BYP41 was more tolerant and showed monophasic and slow-killing dynamic reminiscent of tolerance phenotype defined in bacteriology (eight biological replicates) (B). Intracellular BYP41 was not responsive to either micafungin or caspofungin, whereas intracellular parental strains showed 1,000- to 10,000-fold killing compared to petite strains (four biological replicates) (C). Intracellular BYP40 and CBS138 were outcompeted by BYP41 and D5, respectively, under micafungin treatment (three biological replicates, ****<0.00001, two-tailed t-test) (D and E). BYP40 and BYP41 were equally killed by AMB in either planktonic (eight biological replicates) or intracellular conditions (four biological replicates) (F).CC BY · PubMed Central
Fig 5 In-vivo competition of petite and their parental strains in gut colonization and systemic infection mice models. The fecal samples of CBS138-GFP and non-labeled CBS138 were collected at days 1, 3, 5, and 7, plated on agar YPD plates, and the number of GFP- and non-fluorescent colonies were enumerated. Our gut colonization model showed a slight fitness cost of genomic GFP integration in the context of gut colonization (5 mice per each group, each dot represents one mouse) (A). Both BYP41 (B) and D5 (C) were outcompeted by their parental strains in the context of gut colonization models. Genomic GFP integration carried a significant fitness cost at day 7 in the kidney (D), whereas it did not impact fitness in the spleen (four mice per each timepoint; each dot represents one mouse) (E). Similar to gut colonization, BYP41 was outcompeted by BYP40 in both immunocompromised (F and G) and immunocompetent mice (H and I).
Fig 5 In-vivo competition of petite and their parental strains in gut colonization and systemic infection mice models. The fecal samples of CBS138-GFP and non-labeled CBS138 were collected at days 1, 3, 5, and 7, plated on agar YPD plates, and the number of GFP- and non-fluorescent colonies were enumerated. Our gut colonization model showed a slight fitness cost of genomic GFP integration in the context of gut colonization (5 mice per each group, each dot represents one mouse) (A). Both BYP41 (B) and D5 (C) were outcompeted by their parental strains in the context of gut colonization models. Genomic GFP integration carried a significant fitness cost at day 7 in the kidney (D), whereas it did not impact fitness in the spleen (four mice per each timepoint; each dot represents one mouse) (E). Similar to gut colonization, BYP41 was outcompeted by BYP40 in both immunocompromised (F and G) and immunocompetent mice (H and I).CC BY · PubMed Central
Fig 6 BYP41 shows an improved survival in systemic infection mice treated with humanized dose of caspfungin (5 mg/kg) administered 2 h prior (A and B) or 4 h post infection (C and D).
Fig 6 BYP41 shows an improved survival in systemic infection mice treated with humanized dose of caspfungin (5 mg/kg) administered 2 h prior (A and B) or 4 h post infection (C and D).CC BY · PubMed Central

Verification

Claims the paper makes

29 Valid · 4 Not valid · 5 Not checked · 114 Own results and interpretations

101 more claims · 9 with their cited sources checked

Create a free account to see all 152 claims and every source verdict.

See all claims — free account
  • Probably not a substantial claim. 19
  • It may state two separate claims as one. 30

Create a free account to see these claims.

Citations

Cites

Show all 65 references

Cited by

See all 27

Metadata

Authors
Arastehfar, A., Daneshnia, F., Hovhannisyan, H., Fuentes, D., Cabrera, N., Quinteros, C., Ilkit, M., Ünal, N., Hilmioğlu-Polat, S., Jabeen, K., Zaka, S., Desai, J. V., Lass-Flörl, C., Shor, E., Gabaldon, T., & Perlin, D. S.
Affiliations
  • Harvard University (US)
  • Barcelona Supercomputing Center (ES)
  • Division of Mycology, Faculty of Medicine, University of Çukurova , Adana, Turkey
  • Cukurova University (TR)
  • Division of Mycology, Faculty of Medicine, University of Ege , Izmir, Turkey
  • Aga Khan University (PK)
  • Hackensack Meridian Health (US)
  • Medical University of Innsbruck , Innsbruck, Austria
  • Life Sciences Programme, Supercomputing Center (BSC-CNS) , Barcelona, Spain
Corresponding author
Perlin, David S.
Venue
mBio
Published
2023-10-31
Volume
14
Issue
5
Pages
e0118023-e0118023
ISSN
2150-7511 (ISSN-L)
OpenAlex
W4387157203
Cited by
27
References
65
Citations by year
2026: 11 · 2025: 10 · 2024: 6
FWCI
5.55
Type
journal article
Language
en
Open access
Licence
Locations
  • mBio (publishedVersion, cc-by)
  • bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion, cc-by-nc-nd)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • PubMed Central (submittedVersion, cc-by-nc-nd)
  • eCommons - AKU (Aga Khan University) (submittedVersion, cc-by)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
HHS | National Institutes of Health (R01AI109025)
Topics
  • Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Fungal and yeast genetics research
  • Health Sciences › Medicine › Infectious Diseases › Fungal Infections and Studies
Keywords
Candida glabrata, small colony variants, antifungal resistance, macrophage infection, host inflammatory response, type I interferon, mitochondrial mutations, in vivo fitness, intestinal colonization, systemic infection, clinical isolates, fungal pathogens, host-pathogen interaction, respiratory deficiency, intracellular survival

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-09, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-09 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Overlooked Candida glabrata petites are echinocandin tolerant, induce host inflammatory responses, and display poor in vivo fitness. https://app.cochat.ai/papers/10.1128/mbio.01180-23
The paper
Arastehfar, A., Daneshnia, F., Hovhannisyan, H., Fuentes, D., Cabrera, N., Quinteros, C., Ilkit, M., Ünal, N., Hilmioğlu-Polat, S., Jabeen, K., Zaka, S., Desai, J. V., Lass-Flörl, C., Shor, E., Gabaldon, T., & Perlin, D. S. (2023). Overlooked Candida glabrata petites are echinocandin tolerant, induce host inflammatory responses, and display poor in vivo fitness. mBio. https://doi.org/10.1128/mbio.01180-23

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.